Indaptus Therapeutics Inc... (INDP)
Indaptus Therapeutics Statistics
Share Statistics
Indaptus Therapeutics has 16.03M shares outstanding. The number of shares has increased by 68.98% in one year.
| Shares Outstanding | 16.03M |
| Shares Change (YoY) | 68.98% |
| Shares Change (QoQ) | 20.1% |
| Owned by Institutions (%) | 6.71% |
| Shares Floating | 12.9M |
| Failed to Deliver (FTD) Shares | 38 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 131.09K, so 0.91% of the outstanding shares have been sold short.
| Short Interest | 131.09K |
| Short % of Shares Out | 0.91% |
| Short % of Float | 1.99% |
| Short Ratio (days to cover) | 1.66 |
Valuation Ratios
The PE ratio is -0.52 and the forward PE ratio is -0.75. Indaptus Therapeutics's PEG ratio is 0.04.
| PE Ratio | -0.52 |
| Forward PE | -0.75 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 2 |
| P/FCF Ratio | -0.64 |
| PEG Ratio | 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Indaptus Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.95 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-2.15M |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -77.36% in the last 52 weeks. The beta is 1.26, so Indaptus Therapeutics's price volatility has been higher than the market average.
| Beta | 1.26 |
| 52-Week Price Change | -77.36% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 1.14 |
| Relative Strength Index (RSI) | 38.28 |
| Average Volume (20 Days) | 426.2K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -15.37M |
| Net Income | -15.02M |
| EBITDA | -15.37M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.61 |
Balance Sheet
The company has 5.79M in cash and 84.16K in debt, giving a net cash position of 5.7M.
| Cash & Cash Equivalents | 5.79M |
| Total Debt | 84.16K |
| Net Cash | 5.7M |
| Retained Earnings | -60.44M |
| Total Assets | 7.34M |
| Working Capital | 3.22M |
Cash Flow
In the last 12 months, operating cash flow was -12.32M and capital expenditures 0, giving a free cash flow of -12.32M.
| Operating Cash Flow | -12.32M |
| Capital Expenditures | 0 |
| Free Cash Flow | -12.32M |
| FCF Per Share | -1.32 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for INDP is $8.5, which is 1670.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.5 |
| Price Target Difference | 1670.8% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Jul 27, 2021. It was a backward split with a ratio of 1:4.
| Last Split Date | Jul 27, 2021 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | -16.65 |
| Piotroski F-Score | 2 |